Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older

International Urology and Nephrology

Volumn 40, Issue 4, 2008, Pages 921-931

  Safarinejad, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cross sectional studies; Epidemiology; Prevalence; Prostate; Prostatic hypertrophy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CALORIC INTAKE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ECHOGRAPHY; HEART DISEASE; HUMAN; IMPAIRED BLADDER EMPTYING; INTERVIEW; IRAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MICTURITION DISORDER; NOCTURIA; PREVALENCE; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SCORING SYSTEM; TUMOR VOLUME; URINARY FREQUENCY; URINE FLOW RATE; UROFLOWMETRY;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; HUMANS; INCIDENCE; IRAN; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; RISK FACTORS;

EID: 56249104455     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-008-9338-7     Document Type: Article

References (23)

1. Berry SJ, Coffey DS, Walsh PC et al (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474-479
2. Roehrborn CG, McConnell JD (2002) Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ (eds) Campbell's urology, 8th edn. WB Saunders Co, Philadelphia, pp 1297-1336
3. Barry MJ, Beckley S, Boyle P et al (1992) Importance of understanding the epidemiology and natural history of BHP. In: Cockett ATK, Aso Y, Chatelain C, Denis L, Griffiths K, Khoury S, Murphy G (eds) Proceedings of the International Consultation on Benign Prostatic Hyperplasia (BPH), Paris, 26-27 June, 1991. S. C. I., Paris, pp 13-21
4. Chute CG, Panser LA, Girman CJ et al (1993) The prevalence of prostatism: A population-based survey of urinary symptoms. J Urol 150:85-89
5. Tsukamoto T, Kumamoto Y, Masumori N et al (1995) Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J Urol 154:391-395
6. Bosch JL, Hop WC, Kirkels WJ et al (1995) The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: Prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 75:622-630
7. Garraway WM, Collins GN, Lee RJ (1991) High prevalence of benign prostatic hypertrophy in the community. Lancet 338:469-471
8. Jacobsen SJ, Girman CJ, Guess HA et al (1995) New diagnostic and treatment guidelines for benign prostatic hyperplasia: Potential impact in the United States. Arch Intern Med 155:477-481
9. Fay R (1985) Prostate obstruction in Chinese population. In: Hinman F Jr (ed) Benign prostatic hyperplasia. Springer, Berlin Heidelberg New York, pp 26-29
10. McConnell JD (1997) Epidemiology, etiology, pathophysiology and diagnosis of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Stamey TA, Vaughan SD Jr (eds) Campbell's urology, 7th edn. WB Saunders Co, Philadelphia, pp 1429-1452
11. Choi J, Ikeguchi EF, Lee SW (2002) Is the higher prevalence of benign prostatic hyperplasia related to lower urinary tract symptoms in Korean men due to a high transition zone index? Eur Urol 42:7-11
12. Barry MJ, Williford WO, Chang Y et al (1995) Benign prostatic hyperplasia specific health status measures in clinical research: How much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol 154:1770-1774
13. Napalkov P, Maisonneuve P, Boyle P (1995) Geographical and temporal patterns of incidence and mortality from prostate cancer. Urology 46:47-55
14. Stephenson WP, Chute CG, Guess HA et al (1991) Incidence and outcome of surgery for benign prostatic hyperplasia among residents of Rochester, Minnesota: 1980-87. A population-based study. Urology 38:32-42
15. Wei JT, Calhoun E, Jacobsen SJ (2005) Urologic diseases in America project: Benign prostatic hyperplasia. J Urol 173:1256-1261
16. Tan HY, Choo WC, Archibald C et al (1997) A community-based study of prostatic symptoms in Singapore. J Urol 157:890-893
17. Chicharro-Molero JA, Burgos-Rodriguez R, Sanchez-Cruz JJ et al (1998) Prevalence of benign prostatic hyperplasia in Spanish men 40 years old or older. J Urol 159:878-882
18. Ozturk A, Serel TA, Kosar A et al (2000) Prevalence of benign hypertrophy of the prostate in Turkish men hospitalized in urology. Prog Urol 10:568-570
19. Garraway WM, Russel EB, Lee RJ et al (1993) Impact of previously unrecognized benign prostatic hyperplasia on the lives of middle-aged and elderly men. Br J Gen Pract 43:318-321
20. Roberts R, Tsukamoto T, Kumamoto Y et al (1997) Association between cigarette smoking and prostatism in a Japanese community. Prostate 30:154-159
21. Meigs JB, Mohr B, Barry MJ et al (2001) Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 54:935-944
22. Giovannucci E, Rimm EB, Chute CG et al (1994) Obesity and benign prostatic hyperplasia. Am J Epidemiol 140:989-1002
23. Parsons JK, Carter HB, Partin AW et al (2006) Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab 91:2562-2568